Wyeth taps Cost to head corporate affairs dept.

Wyeth hired Timothy Cost to head its corporate affairs department, replacing Marily Rhudy, who is retiring.

Cost joins the company from Philadelphia food services firm Aramark, where he was EVP, corporate affairs. He becomes senior vice president, corporate affairs, reporting to president and CEO Bernard Poussot. 

Prior to joining Aramark in 2003, he had spent many years in the pharmaceutical industry, serving as SVP, communications and strategy for Centocor, VP, investor relations and corporate intelligence for Bristol-Myers Squibb and SVP, corporate affairs for Pharmacia. Poussot said in a statement: “His extensive and broad experience, especially in the biotechnology and pharmaceutical sectors, will help us as we continue to deliver innovative new products and navigate the changing business environment.”

Rhudy joined Wyeth in 1993 as assistant VP, professional relations for pharmaceuticals and worked her way up while building the public affairs function, rising to SVP, corporate public affairs in 2004.

She had previously served on the White House Health Care Professionals Task Force on Health Care Reform.

Poussot credited Rhudy with having “built an outstanding public affairs team that has forged strong external relationships to raise the level of awareness of Wyeth's contributions to healthcare.” 
You must be a registered member of MMM to post a comment.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.